Human IFNAR2 Deficiency: Lessons For Antiviral Immunity

被引：0

作者：

Duncan, Christopher ^{[1
]}

Mohamad, Siti ^{[1
]}

Young, Dan ^{[2
]}

Skelton, Andrew ^{[1
]}

Leahy, Ronan ^{[3
]}

Munday, Diane ^{[2
]}

Butler, Karina ^{[3
]}

Morfopoulou, Sofia ^{[4
]}

Brown, Julianne ^{[5
]}

Hubank, Mike ^{[4
]}

Connell, Jeff ^{[6
]}

Gavin, Patrick ^{[3
]}

McMahon, Cathy ^{[3
]}

Dempsey, Eugene ^{[7
]}

Lynch, Niamh ^{[8
]}

Jacques, Thomas ^{[5
]}

Valappil, Manoj ^{[9
]}

Cant, Andrew ^{[1
]}

Engelhardt, Karin ^{[1
]}

Breuer, Judith ^{[4
]}

Randall, Richard ^{[2
]}

Hambleton, Sophie ^{[1
]}

机构：

[1] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England

[2] Univ St Andrews, St Andrews KY16 9AJ, Fife, Scotland

[3] Our Ladys Childrens Hosp, Dublin, Ireland

[4] UCL, London WC1E 6BT, England

[5] Great Ormond St Hosp Sick Children, London, England

[6] Univ Coll Dublin, Dublin, Ireland

[7] Cork Univ Matern Hosp, Cork, Ireland

[8] Bon Secours Hosp, Cork, Ireland

[9] Publ Heath England Lab, Newcastle, NSW, Australia

来源：

CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 2015年 / 182卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

O02

引用

页码：1 / 2

页数：2

共 50 条

[21] Mammalian type I interferon receptors consists of two subunits: IFNaR1 and IFNaR2
Kim, SH
Cohen, B
Novick, D
Rubinstein, M
GENE, 1997, 196 (1-2) : 279 - 286
[22] Spotlight: "Human STAT2 deficiency: a severe defect of antiviral immunity"
Bucciol, Giorgia
Meyts, Isabelle
GENES AND IMMUNITY, 2024, 25 (03) : 261 - 263
[23] Regulated proteolysis of the IFNaR2 subunit of the interferon-alpha receptor
Abu Z M Saleh
Aaron T Fang
Allison E Arch
Divas Neupane
Ashraf El Fiky
John J Krolewski
Oncogene, 2004, 23 : 7076 - 7086
[24] Regulated proteolysis of the IFNaR2 subunit of the interferon-alpha receptor
Saleh, AZM
Fang, AT
Arch, AE
Neupane, D
El Fiky, A
Krolewski, JJ
ONCOGENE, 2004, 23 (42) : 7076 - 7086
[25] Relevance of IFNAR2 variants in the mortality of patients with severe COVID-19
Fricke-Galindo, I.
Martinez-Morales, A.
Perez-Rubio, G.
Buendia-Roldan, I.
Chavez-Galan, L.
Hernandez-Zenteno, R. D. J.
Guzman-Guzman, I. P.
Falfan-Valencia, R.
EUROPEAN RESPIRATORY JOURNAL, 2022, 60
[26] IFN-α receptor 2 (IFNAR2) expression and interferon resistance in HCV patients
Trali, G.
Naveed, A.
Rashid, A.
Gul, A.
Khan, R.
Bashir, Q.
JOURNAL OF VIRAL HEPATITIS, 2012, 19 : 11 - 12
[27] IFNAR2 relevance in the clinical outcome of individuals with severe COVID-19
Fricke-Galindo, Ingrid
Martinez-Morales, Alfonso
Chavez-Galan, Leslie
Ocana-Guzman, Ranferi
Buendia-Roldan, Ivette
Perez-Rubio, Gloria
Hernandez-Zenteno, Rafael de Jesus
Veronica-Aguilar, Abigail
Alarcon-Dionet, Aime
Aguilar-Duran, Hiram
Gutierrez-Perez, Ilse Adriana
Zaragoza-Garcia, Oscar
Alanis-Ponce, Jesus
Camarena, Angel
Bautista-Becerril, Brandon
Nava-Quiroz, Karol J. J.
Mejia, Mayra
Guzman-Guzman, Iris Paola
Falfan-Valencia, Ramces
FRONTIERS IN IMMUNOLOGY, 2022, 13
[28] Structural basis of the differential proinflammatory signaling of type I interferons through IFNAR1 and IFNAR2 receptors
de Weerd, Nicole A.
Gould, Jodee A.
Fenner, Jennifer E.
Scott, Bernadette
Hertzog, Paul J.
INFLAMMATION RESEARCH, 2005, 54 : S161 - S161
[29] IFNAR1 and IFNAR2 polymorphisms confer susceptibility to multiple sclerosis but not to interferon-beta treatment response
Leyva, L
Fernández, O
Fedetz, M
Blanco, E
Fernández, VE
Oliver, B
León, A
Pinto-Medel, MJ
Mayorga, C
Guerrero, M
Luque, G
Alcina, A
Matesanz, F
JOURNAL OF NEUROIMMUNOLOGY, 2005, 163 (1-2) : 165 - 171
[30] Association of IFNAR2 and TYK2 with COVID-19 pathology: current and future
Razavi, Alireza
Raei, Maedeh
Shirato, Ken
FRONTIERS IN IMMUNOLOGY, 2024, 15

← 1 2 3 4 5 →